Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 1476 - 1500 of 1605 in total
Experimental
Experimental
Experimental
DA-6886 has been used in trials studying the treatment of Irritable Bowel Syndrome.
Investigational
Hki 357 is under investigation in clinical trial NCT00550381 (Study Evaluating the Safety, Tolerability, and Pharmacokinetics (PK) of HKI-357 Administered Orally to Healthy Subjects).
Investigational
Experimental
Experimental
Pyrotinib is under investigation in clinical trial NCT03756064 (Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer).
Investigational
Renzapride is currently in Phase III clinical development in the United States for the treatment of constipation-predominant irritable bowel syndrome (IBS-C). It has been suggested that renzapride is effective in the treatment of irritable bowel syndrome with alternating stool pattern. It is being developed by Alizyme of the UK.
Investigational
Investigational
Investigational
Experimental
Vet approved
Displaying drugs 1476 - 1500 of 1605 in total